Canadian Guidelines for Economic Evaluation of Pharmaceuticals
- 1 June 1996
- journal article
- guideline
- Published by Springer Nature in PharmacoEconomics
- Vol. 9 (6), 535-559
- https://doi.org/10.2165/00019053-199609060-00008
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- QALYs, HYEs, and the Loss of InnocenceMedical Decision Making, 1993
- Do Patients?? Evaluations of a Future Health State Change When They Actually Enter That State?Medical Care, 1993
- Cost-effectiveness league tables: More harm than good?Social Science & Medicine, 1993
- Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalitiesJournal of Health Economics, 1992
- Economic evaluation of lipid lowering — A feasibility test of the contingent valuation approachHealth Policy, 1992
- A Clinician's Guide to Cost-Effectiveness AnalysisAnnals of Internal Medicine, 1990
- Principles of Cost-Effective Resource Allocation in Health Care organizationsInternational Journal of Technology Assessment in Health Care, 1990
- Quality-adjusted Life Years, Utility Theory, and Healthy-years EquivalentsMedical Decision Making, 1989
- Time Preference for Health in Cost-Effectiveness AnalysisMedical Care, 1989
- The use of QALYs in health care decision makingSocial Science & Medicine, 1989